Skip to main content

Table 1 Patient demographics and outcomes in both study periods (preCOVID and COVID groups)

From: Impact of the SARS-CoV-2 (COVID19) pandemic on the morbidity and mortality of high risk patients undergoing surgery: a non-inferiority retrospective observational study

PERIOD

PRECOVID

(n= 1649)

PRECOVID ELECTIVE

(n= 1490)

PRECOVID EMERGENT

(n=159)

COVID

(n=763)

COVID

ELECTIVE

(n=585)

COVID

EMERGENT(n=178)

PRECOVID

vs.

COVID (p value)

Age, years

(IC 95 %)

62.2 (61.3 – 62.7)

62 (61.3 - 62.8)

63.7 (60.7 – 66.7)

66.1 (64.6 – 67.7)

63.1 (61.8 – 64.4)

64.6 (61.9 – 67.4)

0.065

Male sex, n (%)

899 (54.5)

807 (54.2)

92 (57.9)

379 (49.7)

281 (48)

98 (55.1)

0.028

SPECIALTY

0.018

Digestive and Gynaecological, n (%)

461 (28)

391 (26.2)

70 (44)

177 (23.2)

125 (21.4)

52 (29.2)

 

Orthopaedics and Trauma, n (%)

294 (17.8)

264 (17.7)

30 (18.9)

140 (18.3)

85 (14.5)

55 (30.9)

 

Plastic and Neck, n (%)

288 (17.5)

276 (18,5)

12 (7.6)

148(19.4)

130 (22.2)

18 (10.1)

 

Cardiovascular and thoracic, n (%)

291 (17.6)

271 (18.2)

20 (12.6)

138 (18.1)

112 (19.2)

26 (14.6)

 

Neurosurgery, n (%)

160 (9.7)

138 (9,3)

22 (13.8)

69 (9.1)

50 (8.5)

19 (10.7)

 

Urology, n (%)

155 (9.4)

150 (10.1)

5 (3.1)

91 (11.9)

83 (14.2)

8 (4.5)

 

DRG SEVERITY

1-2 (%)

1413 (85.7)

1318 (88.5)

95 (59.7)

650 (82.3)

500 (85.5)

128 (71.9)

0.123

3-4 (%)

236 (14.3)

172 (11.5)

64 (40.3)

135 (17.7)

85 (14.5)

50 (28.1)

0.034

DRG RISK

1-2, n (%)

1485 (90.1)

1378 (92.5)

107 (67.3)

650 (85.2)

524 (89.6)

126 (70.8)

0.000

3-4, n (%)

164 (9.9)

113 (7.6)

58 (36.5)

113 (14.8)

61 (10.4)

52 (29.2)

0.000

REINTERVENTION, n (%)

138 (8.4)

112 (7.5)

26 (16.4)

55 (7.2)

38 (6.5)

17 (9.6)

0.375

sICU ADMISSION

Per protocol, n (%)

470 (28.5)

430 (28.9)

40 (25.1)

130 (17)

102 (17.4)

28 (15.7)

0.000

Late admission, n (%)

20 (1.2)

11 (0.7)

9 (5.6)

18 (2.4)

15 (2.6)

3 (1.7)

 

CLAVIEN DINDO

I, n (%)

1445 (87.6)

1370(91.8)

75 (44.8)

580 (76)

503 ( 85.9)

77 (43.3)

 

II, n (%)

84 (5.1)

50 (3.4)

34 (20.6)

108 (14.2)

42 (7.2)

66 (37.1)

 

IIIa, n (%)

9 (0.5)

4 (0.3)

5 (3)

6 (0.8)

2 (0.3)

4 (2.2)

 

IIIb, n (%)

31 (1.9)

20 (1.3)

11 (6.7)

23 (3)

15 (2.6)

8 (4.5)

 

IVa, n (%)

25 (1.5)

13 (0.9)

12 (7.3)

16 (2.1)

10 (1.7)

6 (3.4)

 

IVb, n (%)

24 (1.5)

15 (1)

9 (5.5)

13 (1.7)

8 (1.4)

5 (2.8)

 

V, n (%)

31 (1.9)

18 (1.3)

13 (12.1)

17 (2.2)

5 (0.9)

12 (6.7)

 

III-V

120 (7.3)

70 (4.7)

50 (31.4)

75 (9.8)

40 (6.8)

35 (19.7)

0.037

Length of stay (days)

10 (9-11)

9.1 (8-10.1)

18.7 (14.7-22.7)

9.8 (8.3-11.3)

7.6 (6.5-8.7)

17 (11.5-22.5)

0.774

DESTINATION AT DISCHARGE

Home (%)

63.1

70

58.5

70.9

73.1

63.5

 

Death (%)

1.9

1.2

8.2

2.2

0.9

6.7

0.638

Nursing home (%)

353

28.8

33.3

26.9

26

29.8

 
  1. Both periods (PRECOVID group and COVID group) are subdivided into elective and emergency surgery. DRG: Diagnosis Related Groups. Statistical analysis: Chi-square tests to compare the categorical variables and the subtraction of variables using parametric or non-parametric tests for continuous variables